Pfizer Doesn’t Like Crossover Design For Placebo Patients In COVID-19 Vaccine Trial
Executive Summary
Only vaccinating the placebo group would be much easier once the US FDA grants an EUA for its coronavirus vaccine, Pfizer says.
You may also be interested in...
Unblinding Plans For COVID-19 Vaccine Trials Take Roads Less Travelled
Pfizer relies on investigators to determine when prioritization recommendations apply, Moderna offers unblinding to everyone.
Placebo-Unblinding Should Be Uniform Across COVID Vaccine Trials, Advisory Committee Says
US FDA’s outside advisors say Moderna should offer vaccine to placebo-arm patients when they are eligible, the same plan adopted for the Pfizer/BioNTech COVID-19 vaccine.
US FDA’s Vaccine Advisory Committee Roster Tweaked For Moderna Review
After the various turnovers, the panel will be one person smaller, and while the agenda includes familiar topics, including maintaining placebo controls after a vaccine is available, the presentation order will be different.
Existing Subscriber?
Sign in to continue reading.
Need a specific report? 1000+ reports available
Buy Reports
Need a specific report? 1000+ reports available
Buy Reports
New to Pink Sheet?
Start a free trial today!
Register for our free email digests:
Register for our free email digests: